Home » Tenders » Europe » Germany » Contract notice: Pharmaceutical products Tender, Germany - 15109979

Contract notice: Pharmaceutical products Tender, Germany - 15109979

AOK SACHSEN-ANHALT has floated a tender for Contract notice: Pharmaceutical products. The project location is Germany and the tender is closing on 27 Jun 2019. The tender notice number is 286473-2017, while the TOT Ref Number is 15109979. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Germany

Summary : Contract notice: Pharmaceutical products

Deadline : 27 Jun 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 15109979

Document Ref. No. : 286473-2017

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AOK SACHSEN-ANHALT
Office Name: AOK Sachsen-Anhalt
Address: Lüneburger Str. 4
Town: Magdeburg
Postal Code: 39106

Attention: Sabine Eichhorn
Phone: +49 391287845301
Fax: +49 3912878845301
Germany
Email :openhouse@san.aok.de

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: Not specified
CPV code: 33600000, 33600000
CPV Description: Conclusion of non-exclusive discount agreements pursuant to section 130a para. 8 SGB V on medicinal products with the active substance fusidic acid (ATC: D06AX01) with an option at any time within the framework of an "open-house model" Of non-exclusive discount agreements pursuant to section 130 a (8) SGB V relating to medicinal productstoff fusidic acid (ATC: D06AX01) under a so-called "open-house model" Given uniform contract conditions and a standardized access method, all qualified and interested pharmaceutical companies or communities of pharmaceutical companies in the degree or joining a discount contract under - 130 is a. Para. 8 SGB V to the above-mentioned active substanceoffered. Interested pharmaceutical companies can request the participation documents and the respective contract at the contact address given under I.1). The prerequisite for the conclusion of a contract is that the interested pharmaceutical company submits and submits the requested participation documents in full and signed. With any pharmaceutical companyA contract is concluded. An exclusivity is not given. The accession or conclusion of the contract may take place at any time and under the same conditions. Individual contract negotiations are not carried out. The earliest start of the contract is 1.9.2017. The term of the contract is limited to 24 months. The VertRag shall terminate on 31.8.2019, irrespective of the start of the contract.

If the AOK Sachsen-Anhalt publishes exclusive contracts for the active substances within the term of the contract pursuant to the relevant provisions of the German law, the contracts concluded within the scope of this publication shall be terminated in accordance with the contractual provisions In the present publicationG does not concern the award of a public contract within the meaning of - 103 GWB or of the law of consortium. In order to ensure the widest degree of transparency for the intended conclusion of the contract, the supplement is published in the Official Journal of the European Union. In the absence of a corresponding publication form, the contract will be publishedused. The resulting conceptual specifications, such as the "open procedure" procedure, are solely due to the use of this publication form and to the publishing platform connected.

Offer form.

Declaration of Conformity
Internet address (URL):
Directive: Classical Directive (2004/18/EC)